Turn Therapeutics Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-26.
Turn Therapeutics Inc. filed a Form D notice of an exempt securities offering with the SEC on August 26, 2026. Turn Therapeutics Inc. trades on Nasdaq as TTRX; it was formerly Global Health Solutions, Inc. The filing reports $1.65M sold. Its industry group is Biotechnology. It names Bradley Burnam (Executive Officer, Director), Zuraiz Chaudhary (Executive Officer), Martin Dewhurst (Director) (SEC Form D, August 26, 2026).
In its own words: “Advancing Non-Systemic Medicines for Inflammatory Skin Diseases Turn Therapeutics develops first-in-class topical therapies that act within the skin to prevent unnecessary immune activation without systemic exposure or injections.” (turntherapeutics.com, checked November 1, 2026)
Who owns Turn Therapeutics Inc.?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Turn Therapeutics Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Turn Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-26 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Turn Therapeutics Inc.
Free to see. No signup.
More on the people and the money behind Turn Therapeutics Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in August 2026, largest first.
Get an email when Turn Therapeutics Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Turn Therapeutics Inc. raises, hires or launches. No email unless you switch it on.
Watch Turn Therapeutics Inc. →Get the full cited report on Turn Therapeutics Inc.
What the filing shows about Turn Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Turn Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Turn Therapeutics Inc.'s address as 250 North Westlake Blvd., #210, Westlake Village, CA 91362.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Turn Therapeutics Inc. is a registered filer with the SEC (CIK 2023016) and has filed since 2026-08-26. 1 filing is on record, the latest on 2026-08-26.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Turn Therapeutics Inc.'s Form D of 2026-08-26 names Bradley Burnam, Zuraiz Chaudhary, Martin Dewhurst and 4 more as its officers, directors or promoters.
Its new offerings report $1.65M sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $1.65M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Turn Therapeutics Investor relations (IR) website contains information about our business for stockholders, potential investors, and financial analysts.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Bradley Burnam is named as Executive Officer and Director on the Form D that Turn Therapeutics Inc. filed with the SEC on 26 August 2026, one of 7 people that filing names.
Zuraiz Chaudhary is named as Executive Officer on the Form D that Turn Therapeutics Inc. filed with the SEC on 26 August 2026, one of 7 people that filing names.
Martin Dewhurst is named as Director on the Form D that Turn Therapeutics Inc. filed with the SEC on 26 August 2026, one of 7 people that filing names.
Andrew Gengos is named as Director on the Form D that Turn Therapeutics Inc. filed with the SEC on 26 August 2026, one of 7 people that filing names.
Arthur Golden is named as Director on the Form D that Turn Therapeutics Inc. filed with the SEC on 26 August 2026, one of 7 people that filing names.
Kent Kester is named as Director on the Form D that Turn Therapeutics Inc. filed with the SEC on 26 August 2026, one of 7 people that filing names.
Neilesh Ghodadra is named as Executive Officer and Director on the Form D that Turn Therapeutics Inc. filed with the SEC on 26 August 2026, one of 7 people that filing names.
7 people named on the filing — 3 holding an executive role and 4 as directors only.
Named as of the 2026-08-26 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Turn Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Turn Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Turn Therapeutics Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Turn Therapeutics Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Turn Therapeutics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (ir.turntherapeutics.com).
Each opens in a new tab, filled in for Turn Therapeutics Inc.. With no account yet, you sign up free and land on the result.
On these lists: Los Angeles raises, week of 2026-08-24 · Biotech raises, week of 2026-08-24 · Biotech raises in Los Angeles
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/turn-therapeutics-inc-form-d-26000001